Synergy Pharmaceuticals is a biopharmaceutical company focusing on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its only commercial product is plecanatide (brand name Trulance) which is used for the treatment of chronic idiopathic constipation and irritable bowel syndrome. The company also develops dolcanatide, a product candidate to treat mild-to-moderate ulcerative colitis.